-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
MI 14
![{PARAM:[Name]}({[CAS]})](https://resource.bocsci.com/structure/1715934-43-22d.gif)
| Category | Hepatitis C Virus (HCV) |
| CAS | 1715934-43-2 |
| Description | MI 14 is a PI 4-K IIIβ inhibitor with IC50 value of 54 nM. It shows antiviral activity against single-stranded positive sense RNA viruses in HeLa cell-based assays. |
Product Information
| Synonyms | 1715934-43-2;MI 14;MI-14;MI14;CHEMBL3914714;N-(2-((6-chloro-3-(3-(N,N-dimethylsulfamoyl)phenyl)-2-methylimidazo[1,2-b]pyridazin-8-yl)amino)ethyl)acetamide;SCHEMBL24477274;BDBM50199887;AKOS027470223;NCGC00476209-02;DA-75530;N-[2-[[6-chloro-3-[3-(dimethylsulfamoyl)phenyl]-2-methylimidazo[1,2-b]pyridazin-8-yl]amino]ethyl]acetamide; |
| IUPAC Name | N-[2-[[6-chloro-3-[3-(dimethylsulfamoyl)phenyl]-2-methylimidazo[1,2-b]pyridazin-8-yl]amino]ethyl]acetamide |
| Molecular Weight | 450.94 |
| Molecular Formula | C19H23ClN6O3S |
| Canonical SMILES | O=C(C)NCCNC1=CC(Cl)=NN2C1=NC(C)=C2C3=CC(S(=O)(N(C)C)=O)=CC=C3 |
| InChI | InChI=1S/C19H23ClN6O3S/c1-12-18(14-6-5-7-15(10-14)30(28,29)25(3)4)26-19(23-12)16(11-17(20)24-26)22-9-8-21-13(2)27/h5-7,10-11,22H,8-9H2,1-4H3,(H,21,27) |
| InChIKey | PSTAJIONBVMKLA-UHFFFAOYSA-N |
| Purity | ≥98% by HPLC |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |